




Raihana Yasmin , Sangeeta Gogoi
, Jumi Bora
et al.
J Cancer Prev 2023; 28(3): 77-92
https://doi.org/10.15430/JCP.2023.28.3.77Soo In Choi , Nayoung Kim
, Ryoung Hee Nam
et al.
J Cancer Prev 2023; 28(3): 93-105
https://doi.org/10.15430/JCP.2023.28.3.93Shenglong Li , Hao Zheng
, Qinghong Ge
et al.
J Cancer Prev 2023; 28(3): 106-114
https://doi.org/10.15430/JCP.2023.28.3.106Nur Mahirah Amani Binti Mohammad , Mohd Razif Shahril
, Suzana Shahar
et al.
J Cancer Prev 2022; 27(4): 208-220
https://doi.org/10.15430/JCP.2022.27.4.208Hyuntak Na , Jeeyoo Lee
, Sooyoung Cho
et al.
J Cancer Prev 2022; 27(4): 229-238
https://doi.org/10.15430/JCP.2022.27.4.229Nangwon Yee , Hyeonjin Kim
, Eungyung Kim
et al.
J Cancer Prev 2022; 27(4): 239-246
https://doi.org/10.15430/JCP.2022.27.4.239Soojung Jin , Jung-ha Park
, Hee Jung Yun
et al.
J Cancer Prev 2022; 27(4): 221-228
https://doi.org/10.15430/JCP.2022.27.4.221Hyuntak Na , Jeeyoo Lee
, Sooyoung Cho
et al.
J Cancer Prev 2022; 27(4): 229-238
https://doi.org/10.15430/JCP.2022.27.4.229Nur Mahirah Amani Binti Mohammad , Mohd Razif Shahril
, Suzana Shahar
et al.
J Cancer Prev 2022; 27(4): 208-220
https://doi.org/10.15430/JCP.2022.27.4.208Nangwon Yee , Hyeonjin Kim
, Eungyung Kim
et al.
J Cancer Prev 2022; 27(4): 239-246
https://doi.org/10.15430/JCP.2022.27.4.239JunPyo Han , Yujin Jang
, Dong Yeop Shin
et al.
J Cancer Prev 2022; 27(4): 199-207
https://doi.org/10.15430/JCP.2022.27.4.199The aim of the journal is to promote an increased awareness of all aspects that ultimately lead to cancer prevention. The journal publishes important original research articles, reviews, editorials, short communications, and letters to the editor with the multi-disciplinary perspectives in the areas of carcinogenesis, chemoprevention, molecular epidemiology, and cancer biology. The journal comprises basic, clinical, and translational research with special attention given to molecular and cellular mechanisms of cancer chemopreventive agents as well as identification of novel risk factors and biomarkers of cancer.
+82-64-702-2687